Skip to main content

Table 1 Patient population characteristics

From: Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer

 

n

%

Patients

60

100

 Male

36

60

 Female

24

40

Age at diagnosis (years)

 Median

62

 

 Range

43–81

 

Age at testing (years)

 Median

64

 

 Range

43–81

 

Personal history

 Available

49

81.7

 Other cancera

10

20.4

  Breast

5b

 

  Ovarian

0

 

  Other

6

 

 No other cancer

39

79.6

 Not available

11

18.3

Family historyc

 Available

32

53.3

 Cancera

23

71.9

  Pancreatic

4

 

  Breast

12

 

  Ovarian

1

 

  Other

16

 

 No cancer

9

28.1

 Not available

28

46.7

  1. a some patients have history of ≥2 cancers; b 5 + 1 in situ; c first-grade and second-grade relatives